Nearly two years after Takeda pulled its US marketing application for a vaccine against dengue fever, MSD has advanced a rival shot into phase 3. The international MOBILIZE-1 trial is looking at a ...

Major changes to medical device regulations in the UK have come into force with an overhaul of post-market surveillance requirements.

RFK Jr has removed all 17 members of the CDC's vaccine advisory committee in a move that some fear could lead to restrictions on immunisation access ...

The first half of 2025 has been marked by a surge in strategic activity across the global healthcare, life sciences, and ...

Here, Michelle Tsai – chief operating officer at iOnctura – and Shane Olwill – chief development officer at Asgard ...

Onsite in Chicago at ASCO 2025, web editor Nicole Raleigh sat down with Dr Danny Nguyen, medical oncologist and haematologist ...

The Association of the British Pharmaceutical Industry (ABPI) has said that the new 10-year plan for the NHS has underplayed ...

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

A European pharma trade organisation has said that a new strategy launched by the EU to bolster the region's standing in life ...

The latest round of R&D funding from the Novo Nordisk Foundation (NNF) has been announced and will go towards projects in biomanufacturing, cardiometabolic diseases, and artificial intelligence ...

A smartphone app for depression developed by Otsuka and Click Therapeutics has been launched in Great Britain, its first European market ...